跳至主要内容
临床试验/NCT02545088
NCT02545088已完成不适用

New Technology for Individualised, Intensive Training of Gait After Stroke- Phase II Trials, Study II

Danderyd Hospital2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2015年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
48
试验地点
2
主要终点
Change in 6 min walk test

研究概览

简要总结

The overall purpose of this project is to establish the added value of training with the Hybrid Assistive Limb (HAL) exoskeleton system as part of regular rehabilitation intervention programs after stroke.

The main specific aims are:

(i) to compare potential effects on functioning and disability of gait and mobility training long-term after stroke by comparing A) HAL-training combined with conventional rehabilitation interventions to B) conventional rehabilitation interventions without HAL and to C) no intervention.

详细描述

The effectiveness of the interventions will be assessed in terms aspects of body function, walking ability and endurance as well as level of activity in daily living and participation assessed at the end of intervention and at a 6 and 12 months follow-up.

Intensive gait training with HAL is performed 1 session/day, 3 days/week for 6 weeks and each session will not exceed 60 min of effective walking time with HAL. In addition, each session will include conventional gait training that will not exceed 30 min effective training time. To standardize the training procedure, training with HAL is performed on a treadmill and to enable body weight support. Body weight support is used to prevent falls and to unburden the weight of the suit (9 kg). The training program is performed by physiotherapists, trained in the HAL method and the study procedures. At the end of the 6 weeks, the physiotherapist that has been engaged in the patient's conventional training will perform 1-2 home visits to inform/educate the patient and those who are providing assistance to the patient in how the patient can make use of any gains in gait function during activities of daily living.

The 1st control group will receive conventional gait training performed 1 session/day, 3 days/week for 6 weeks that will not exceed 1h 30 min effective training time.

The 2nd control group will not receive an intervention. The conventional gait training is performed according to current best evidence based practice and may include over ground walking with assistance and/or assistant devices as well as the use of a treadmill and body weight support and training of gait function in activities of daily living

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1-10 years since stroke onset
  • Able to walk but not independently, i.e. need of manual support or close supervision due to lower extremity paresis, FAC score 2-3 or FAC 4 combined with gait speed <0.8m/s according to 10 meter walk test, which corresponds to limitations in community ambulation (Bowden et al 2008)
  • Ability to understand training instructions as well as written and oral study information and to express informed consent or by proxy
  • Body size compatible with the HAL suit.

排除标准

  • Contracture restricting gait movements at any lower limb joint
  • Cardiovascular or other somatic condition incompatible with intensive gait training
  • Severe, contagious infections (e.g. Methicillin Resistant Staphylococcus Aureus (MRSA) or Extended Spectrum Beta Lactamase bacteria).

结局指标

主要结局

Change in 6 min walk test

时间窗: Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention

walking ability and endurance

次要结局

  • Modified Ranking Scale(Assessment at baseline)
  • Fugl Meyer Scale for lower extremities(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Modified Ashworth Scale(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Spasticity measured with Neuroflexor foot module(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Berg Balance Scale(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • 10 meters walk test(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • 2 minutes walk test(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Functional Ambulation Categories(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Borg Rating of Perceived Exertion Scale (RPE)(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Montreal Cognitive Assessment(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Hospital anxiety and Depression Scale(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Stroke Impact Scale(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Barthel Index(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Physical activity in everyday life using SenseWear(Assessment at baseline, after 3 weeks of intervention, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Objectively quantify the impairment caused by a stroke, using the National Institutes of Health Stroke Scale (NIHSS)(Assessment at baseline)
  • Body Mass Index(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Weight(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Height(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Blood pressure(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • HbA1c(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Plasma lipid profile(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Perception of the intervention(after 6 weeks of intervention)
  • Smoking(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Alcohol(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Drug use(Assessment at baseline, after 6 weeks of intervention, 6 and 12 month post intervention)
  • Health care consumption(12 month post intervention)
  • Stroke type and localization(At baseline)
  • Dysexecutive Questionnaire(At baseline)

研究者

发起方
Danderyd Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Susanne Palmcrantz

PhD, Reg physiotherapist

Danderyd Hospital

研究点 (2)

Loading locations...

相似试验

New Technology for Individualised, Intensive... | 临床试验